C3AR1 and stroke disorder: Given the translational hurdles posed by C3aR’s pleiotropic signaling and pharmacological constraints, future research must prioritize mechanistic precision and therapeutic refinement through advanced models and molecular tools to unlock the full potential of complement-targeted interventions in stroke recovery.